NCT03395834 is a NA clinical trial of O3 in Tissue Oxygen Saturation, sponsored by Seoul National University Hospital.

Who is sponsoring NCT03395834?

NCT03395834 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03395834?

Interventions in NCT03395834: O3.

What condition does NCT03395834 study?

NCT03395834 studies Tissue Oxygen Saturation.

Is NCT03395834 still recruiting?

NCT03395834 is currently completed. Last updated 9 July 2019.

Last reviewed 2019-07-09 · How we verify

NCT03395834

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Change of Tissue Oxygenation During a Vascular Occlusion Test Using Two Different NIRS (O3TM vs. INVOS®)

Completed NA Last updated 9 July 2019

What this trial tests

NA trial testing O3 in Tissue Oxygen Saturation in 20 participants. Completed in 20 November 2018.

Timeline

1 February 2018

Primary endpoint
29 October 2018

20 November 2018

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	1 February 2018
Primary completion	29 October 2018
Estimated completion	20 November 2018
Sites	4 locations across South Korea

Drugs / interventions tested

Conditions studied

Tissue Oxygen Saturation — all drugs for Tissue Oxygen Saturation →

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 60, any sex, with Tissue Oxygen Saturation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the change of tissue oxygenation during a vascular occlusion test using two NIRS ( O3TM and INVOS®). NIRS probe will be attached on volunteer's forearm during vascular occlusion test and tissue oxygenation change will be recorded

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of O3

Trials testing the same drug.

NCT05077397 — Is Regional Oxygen Saturation Effective in Predicting Perfusion Parameters and Patient Outcomes in Liver Resection · NA · unknown

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03395834 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 9 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03395834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing